Saniona AB (publ)
SSE:SANION.ST
2.1 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Saniona AB (publ) |
Symbool | SANION.ST |
Munteenheid | SEK |
Prijs | 2.105 |
Beurswaarde | 225,801,245 |
Dividendpercentage | 0% |
52-weken bereik | 1.962 - 10.526 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jorgen Drejer Ph.D. |
Website | https://www.saniona.com |
An error occurred while fetching data.
Over Saniona AB (publ)
Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)